| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 |
| Total Revenue |
-
|
-
|
| Cost of Revenue | 978 |
-
|
|
| Gross Profit | (978) |
-
|
|
| Operating Expenses |
| Research Development |
-
|
-
|
| Selling General and Administrative | 924 | 6 |
| Non Recurring |
-
|
-
|
| Others |
-
|
-
|
| |
| Total Operating Expenses |
-
|
-
|
|
|
| Operating Income or Loss | (1,902) | (6) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | 2,054 | 3 |
| Earnings Before Interest And Taxes | 152 | (3) |
| Interest Expense | 23 |
-
|
| Income Before Tax | 129 | (3) |
| Income Tax Expense |
-
|
-
|
| Minority Interest |
-
|
-
|
| |
| Net Income From Continuing Ops | 129 | (3) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
| Extraordinary Items |
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
| Other Items |
-
|
-
|
|
|
| Net Income | 129 | (3) |
| Preferred Stock And Other Adjustments |
-
|
-
|
|
| Net Income Applicable To Common Shares | $129 | ($3) |
0.34% Nasdaq 
Income Statement
